Medical News

RSS

Siemens Healthcare donates MAGNETOM ESSENZA MRI system to Phoebe Sumter Medical Center

After three long years of hardship to rebuild a cornerstone of the community, the staff of Phoebe Sumter Medical Center welcomed the arrival of a new MAGNETOM® ESSENZA magnetic resonance imaging (MRI) system, compliments of Siemens Healthcare. The new MRI scanner premiered today at the official ribbon-cutting ceremony to mark Siemens' donation after a tornado destroyed the hospital in 2007. State and local political dignitaries and community leaders were on hand for the event.

5 Jun 2010

Maryland doctors to get rewards for cheaper care; In S.D., Sue to open more doc-owned hospitals

CareFirst BlueCross BlueShield, the largest insurer in the Maryland, Washington and Northern Virginia market, will begin offering financial rewards to physicians who improve quality while cutting costs. Beginning on Jan. 1, the insurer plans to recruit doctors "to participate in its new initiative designed to cut down on the number of unnecessary diagnostic tests, emergency room visits and hospital re-admissions. To do so, CareFirst is putting the onus on the 5,000 doctors already in its network to revamp the care provided to their patients — particularly those with chronic diseases or at risk of contracting them — and more carefully consider where they send patients when they need to see a specialist or go to the hospital."

5 Jun 2010

Hip strengthening regimen proves effective at reducing PFP in female runners: Study

A twice weekly hip strengthening regimen performed for six weeks proved surprisingly effective at reducing -- and in some cases eliminating -- knee pain referred to as patellofemoral pain in female runners.

5 Jun 2010

St. Jude Medical to pay $3.7M to resolve allegations of illegal kickbacks

Working with an internal whistleblower, Attorney Warner Mendenhall, the Law firm of McLaughlin and McCaffrey, LLP, and Assistant United States Attorneys Alex Rokakis and Michelle Heyer have worked for four years to expose False Claims by St. Jude Medical, Inc. a cardiac device manufacturer.

5 Jun 2010

Elizabeth Glaser Pediatric AIDS Foundation to join with JFC to celebrate Children's Day

The Elizabeth Glaser Pediatric AIDS Foundation will join with Jewelers for Children and other charities on Sunday to celebrate JFC's Children's Day, which commemorates the jewelry industry's charitable efforts on behalf of children throughout the year. This second annual Children's Day concludes with JFC's 12th annual Facets of Hope dinner held in Las Vegas, Nevada, with the theme It's All About the Kids.

5 Jun 2010

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 (the "notes") are convertible at the option of the holders and will remain convertible at least through July 6, 2010, as provided for in the Indenture governing the notes.

5 Jun 2010

COBRA subsidy starts running out for some as Congress grapples with extension

Howard Kornblum has been watching every penny for the past 15 months and it's about to get worse. After being laid off from his job as a consulting director in Michigan, he took advantage in March 2009 of a federal subsidy to help pay for health insurance.

5 Jun 2010

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

The John Theurer Cancer Center at Hackensack University Medical Center announced today important research findings that will be presented at the American Society of Clinical Oncology annual meeting taking place June 4 - 8, 2010 in Chicago. Research highlights include a comparison of first-line treatments for an aggressive form of lymphoma, the efficacy and safety of a new genetically engineered cancer therapy, and the value of a commonly used tool for staging lymphoma.

5 Jun 2010

Acute neurological toxicity associated with chronic neurological toxicity in patients with high-grade gliomas

Patients with high-grade gliomas who experience acute (early) neurological toxicity during their treatment were more likely to experience chronic (late) neurological toxicity and shortened overall survival, according to researchers from the Kimmel Cancer Center at Jefferson. The study will be presented at the 2010 ASCO Annual Meeting in Chicago (Abstract #2037).

5 Jun 2010

WRNp controls key step in pluripotent stem cell differentiation: Study

A gene shown to play a role in the aging process appears to play a role in the regulation of the differentiation of embryonic stem cells, according to researchers from the Center for Stem Cell Biology and Regenerative Medicine and the Department of Medicine at Thomas Jefferson University.

5 Jun 2010

South Africa prepares health systems for World Cup disaster — but could be overwhelmed

The Associated Press: South Africa is attempting to prepare its emergency services in case of a disaster at the World Cup, which begins next week. "But the public system won't have to cope alone, the chief medical officer for local tournament organizers said in an interview this week. Dr. Victor Ramathesele outlined plans for what he said would be unprecedented coordination between the public system, the military and the private sector in case of emergency during Africa's first World Cup."

5 Jun 2010

Green tea component reduces leukemia cells in patients with CLL

An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) patients who used it in a phase II clinical trial, say researchers at Mayo Clinic.

5 Jun 2010

British PM calls for G8, G20 to reduce maternal mortality, announces new health worker training fund

In a Guardian opinion piece, published on Thursday, British Prime Minister David Cameron says G8 and G20 nations should reduce maternal mortality in developing countries and set "'an ambitious target' of saving three million more lives by 2015," the Guardian reports (Watt, 6/3).

5 Jun 2010

Onyx presents interim results of Phase 1b dose-escalation carfilzomib combination trial for multiple myeloma

Onyx Pharmaceuticals, Inc. today announced updated interim results of the Phase 1b dose-escalation trial, known as the 006 study, evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed and/or refractory myeloma. These data are being presented today at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

5 Jun 2010

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, reported final results from the Phase 2, open-label ENCORE 303 trial in post-menopausal women with advanced, estrogen receptor positive breast cancer who were progressing on aromatase inhibitor therapy.

5 Jun 2010

Sebelius defends Berwick for CMS post

The Wall Street Journal: HHS Secretary Kathleen Sebelius "Thursday rejected criticism of the Obama administration's nominee to run Medicare and Medicaid, saying Republicans were being unfair to Donald Berwick and she was confident he would be confirmed. Dr. Berwick, a Harvard pediatrician and health-quality advocate, has come under sharp attack from Republicans over his ties to Britain's national health system and past writings about how to make health care more efficient.

5 Jun 2010

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

The University of Maryland, Baltimore's Office of Research and Development announced that Encore Path, Inc. of Baltimore signed an exclusive worldwide license agreement for a device technology invented jointly by researchers at the University of Maryland, Baltimore and the University of Maryland Baltimore County that helps stroke patients retrain their bodies to walk.

5 Jun 2010

HHF to open Terni Human Health Bioscience Institute

The Human Health Foundation, a nonprofit organization founded in 2006 to develop and fund biomedical research in Italy, will open the Terni Human Health Bioscience Institute for the investigation of breast, brain and lung cancer on June 7th in Terni, Italy.

5 Jun 2010

Survey: Group insurance rates rise for employers

"Group health insurance rates for small and midsize employers are surging for 2011 renewals, according to a survey by the Council of Insurance Agents & Brokers," Business Insurance reports.

5 Jun 2010

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

Pacific Edge (PEB), a New Zealand-based biomedical company, today announced the successful completion of the European clinical trial for their prognostic gene signature for colorectal cancer. The clinical trial results showed a successful outcome that enables patients diagnosed with UICC stage II or UICC stage III colorectal cancer and with a high risk of disease progression to be identified and treated more appropriately.

5 Jun 2010

Medical News

Siemens Healthcare donates MAGNETOM ESSENZA MRI system to Phoebe Sumter Medical Center

Maryland doctors to get rewards for cheaper care; In S.D., Sue to open more doc-owned hospitals

Hip strengthening regimen proves effective at reducing PFP in female runners: Study

St. Jude Medical to pay $3.7M to resolve allegations of illegal kickbacks

Elizabeth Glaser Pediatric AIDS Foundation to join with JFC to celebrate Children's Day

OSI Pharmaceuticals' 2% Senior Subordinated Notes to remain convertible through July 6, 2010

COBRA subsidy starts running out for some as Congress grapples with extension

John Theurer Cancer Center to showcase treatment advancements for cancer at ASCO 2010

Acute neurological toxicity associated with chronic neurological toxicity in patients with high-grade gliomas

WRNp controls key step in pluripotent stem cell differentiation: Study

South Africa prepares health systems for World Cup disaster — but could be overwhelmed

Green tea component reduces leukemia cells in patients with CLL

British PM calls for G8, G20 to reduce maternal mortality, announces new health worker training fund

Onyx presents interim results of Phase 1b dose-escalation carfilzomib combination trial for multiple myeloma

Positive results from Phase 2, open-label ENCORE 303 trial to be presented at ASCO 2010

Sebelius defends Berwick for CMS post

Encore Path signs license agreement for UMB technology that helps stroke patients redevelop natural gait

HHF to open Terni Human Health Bioscience Institute

Survey: Group insurance rates rise for employers

PEB's European licensee SDX completes clinical trial for prognostic gene signature for colorectal cancer

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News